Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | C1S | P09871 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1761294 | 0.97 | MAPT (0.48) | MAPTGAAALDH1A1TSHRRAPGEF4 | |
| SCHEMBL13619386 | 0.82 | MAPT (0.38) | MAPTGAAALDH1A1TSHRRAPGEF4 | |
| SCHEMBL8033916 | 0.82 | MAPT (0.38) | MAPTGAAALDH1A1TSHRRAPGEF4 | |
| SCHEMBL18593306 | 0.82 | RAPGEF4 (0.47) | MAPTGAAALDH1A1TSHRRAPGEF4 | |
| Hydrochloric Acid SCHEMBL7413150 | 0.80 | RAPGEF4 (0.45) | MAPTGAAALDH1A1RAPGEF4MEN1 | |
| SCHEMBL11582579 | 0.78 | MAPT (0.39) | MAPTGAAALDH1A1RAPGEF4MEN1 | |
| SCHEMBL14701817 | 0.78 | ALDH1A1 (0.42) | MAPTGAAALDH1A1TSHRRAPGEF4 | |
| SCHEMBL11677821 | 0.77 | RAPGEF4 (0.52) | MAPTALDH1A1RAPGEF4CYP1A2CYP3A4 | |
| SCHEMBL22423660 | 0.75 | CYP3A4 (0.36) | MAPTGAAALDH1A1TSHRMEN1 | |
| SCHEMBL1323030 | 0.73 | RAPGEF4 (0.65) | MAPTGAAALDH1A1TSHRRAPGEF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109060739-A | A method of detection hydrogen peroxide | 中国科学院上海微系统与信息技术研究所 | 2018-12-21 | — | — | CN | claimed |
| EP-0918052-B1 | Improved polymeric mdi color | BAYER AG (US) | 2003-05-28 | — | — | EP | claimed |
| CN-119019332-A | 1, 5-Disubstituted-4-bromopyrazole compound and preparation method and application thereof | 赣南师范大学 | 2024-11-26 | — | — | CN | disclosed |
| CN-118184681-A | Spiro 1,2, 4-triazole carbene metal complex, intermediate, preparation method and application thereof | 浙江工业大学 | 2024-06-14 | — | — | CN | disclosed |
| CN-113980001-B | Pyrazolol-pyridazinone coupling compound, pharmaceutical composition thereof and application of pyrazolol-pyridazinone coupling compound in medicines | 贵州医科大学 | 2024-01-30 | — | — | CN | disclosed |
| US-20230382912-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-11-30 | — | — | US | disclosed |
| US-20230382912-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-11-30 | — | — | US | disclosed |
| US-11814381-B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-11-14 | — | — | US | disclosed |
| US-11814381-B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-11-14 | — | — | US | disclosed |
| CN-117050066-A | 2-benzoxazolone derivative and preparation method and application thereof | 广西医科大学 | 2023-11-14 | — | — | CN | disclosed |
| US-20230040909-A1 | INDOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC (US) | 2023-02-09 | — | — | US | disclosed |
| CN-1444477-A | Thrombopoietin mimetics | SMITHKLINE BEECHAM CORP (US) | 2003-09-24 | — | — | CN | disclosed |
| EP-1324998-A1 | NOVEL AMINOTRIAZOLONE COMPOUNDS, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | Les Laboratoires Servier (FR) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002030923-A1 | NOVEL AMINOTRIAZOLONE COMPOUNDS, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | LES LABORATOIRES SERVIER (FR) | 2002-04-18 | — | — | WO | disclosed |
| JP-2002053552-A | METHOD FOR PRODUCING 4,6-DIMETHYLINDOLE AND DERIVATIVE THEREOF | SANKYO CO LTD | 2002-02-19 | — | — | JP | disclosed |
| US-4966623-A | POLLEN INHIBITION | ACKMANN STEPHEN A (US) | 1990-10-30 | — | — | US | disclosed |
| US-4902808-A | HYBRID, POLLEN FORMATION INHIBITOR | ELI LILLY AND COMPANY (US) | 1990-02-20 | — | — | US | disclosed |
| US-4801326-A | PRODUCTION OF HYBRID SEED | ELI LILLY AND COMPANY (US) | 1989-01-31 | — | — | US | disclosed |
| EP-0244075-A1 | Gametocidal pyrazoles | ELI LILLY AND COMPANY (US) | 1987-11-04 | — | — | EP | disclosed |
| EP-0017727-A1 | Polysubstituted diazatricyclic derivatives, processes for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1980-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382912-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | GLP1R, GPR119, GIPR | MAPT 3620/4885GAA 3422/4885ALDH1A1 2311/4885 |
| US-11814381-B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | GLP1R, GPR119, GIPR | MAPT 4437/4885GAA 3870/4885ALDH1A1 2099/4885 |
| US-20230040909-A1 | INDOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS | IDO1, IDO2, INMT | MAPT 960/4885GAA 1428/4885ALDH1A1 477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.